Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review
about
Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South AfricaManagement of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.Tuberculosis treatment and drug regimens.A killer combination that must be stoppedSevere adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort studyNew Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases.Treatment Outcomes of Children with HIV Infection and Drug-Resistant TB in Three Provinces in South Africa, 2005-2008.Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis.Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa.Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
P2860
Q28550587-7210CC48-1CE0-433B-B155-59DCD1BB3C26Q34455442-A5987896-0D27-4CCC-9997-3055741A913EQ35663866-98F9D607-873A-45B6-B5BC-4A1DF8C9CE75Q35854996-C4C4CE62-D83E-42EC-8A8C-AB9277D5D309Q36171130-C1274FBA-310F-4D4A-B478-AF37918CAD6AQ36644842-9691AF8B-ED64-404D-AD56-54A1AC5E9401Q38207924-21B8D806-7497-4107-B243-9ECD14843155Q38346780-5D98F5C3-522E-4A1D-961A-A59BFD27F4EBQ38660254-73BF1414-B7EE-488C-BB4A-F868D752E078Q38684466-37262E1B-0DDB-4FE4-8145-2E6E7BA8C5A6Q39248451-7E17F369-B5A4-4005-95F4-8767CC4DF8C2Q40934368-EE857801-9365-4A88-8F45-40F5DA0742A0Q55547799-A1CBAAE4-3C2A-4310-82C2-A614FD536978Q56889741-F49E78AE-F83D-4CB2-BB89-A9AB2DDB6D41
P2860
Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Use of anti-retroviral therapy ...... regimens: a systematic review
@ast
Use of anti-retroviral therapy ...... regimens: a systematic review
@en
Use of anti-retroviral therapy ...... regimens: a systematic review
@nl
type
label
Use of anti-retroviral therapy ...... regimens: a systematic review
@ast
Use of anti-retroviral therapy ...... regimens: a systematic review
@en
Use of anti-retroviral therapy ...... regimens: a systematic review
@nl
prefLabel
Use of anti-retroviral therapy ...... regimens: a systematic review
@ast
Use of anti-retroviral therapy ...... regimens: a systematic review
@en
Use of anti-retroviral therapy ...... regimens: a systematic review
@nl
P2093
P2860
P31
P921
P3181
P1433
P1476
Use of anti-retroviral therapy ...... regimens: a systematic review
@en
P2093
David J Horne
Dennis Falzon
Holger J Schünemann
Judd L Walson
Matthew Arentz
Michael E Kimerling
Patricia Pavlinac
Sarah Royce
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0047370
P407
P5008
P577
2012-11-05T00:00:00Z